VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $155 | -11.9% | 25,990 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $176 | -8.3% | 25,990 | 0.0% | 0.01% | -17.6% |
| Q4 2022 | $192 | -99.8% | 25,990 | +138.7% | 0.02% | +70.0% |
| Q3 2022 | $108,000 | -9.2% | 10,890 | 0.0% | 0.01% | -9.1% |
| Q2 2022 | $119,000 | -3.3% | 10,890 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $123,000 | -28.1% | 10,890 | 0.0% | 0.01% | -30.8% |
| Q4 2021 | $171,000 | -8.6% | 10,890 | 0.0% | 0.01% | -13.3% |
| Q3 2021 | $187,000 | -20.1% | 10,890 | 0.0% | 0.02% | -21.1% |
| Q2 2021 | $234,000 | +42.7% | 10,890 | 0.0% | 0.02% | +26.7% |
| Q1 2021 | $164,000 | +14.7% | 10,890 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $143,000 | +36.2% | 10,890 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $105,000 | -18.0% | 10,890 | 0.0% | 0.01% | -20.0% |
| Q2 2020 | $128,000 | +13.3% | 10,890 | 0.0% | 0.02% | -6.2% |
| Q1 2020 | $113,000 | – | 10,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |